Get startedLog in
    Picture of R J Biotech logo

    536456 — R J Biotech Income Statement

    0.000.00%
    in flag iconLast trade - 00:00
    Consumer DefensivesBalancedMicro Cap
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual income statement for R J Biotech, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

    2018
    March 31st
    2019
    March 31st
    2020
    March 31st
    2021
    March 31st
    2022
    March 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSARS
    Standards:
    IAS
    IAS
    IAS
    IAS
    IAS
    Status:FinalFinalFinalFinalFinal
    Revenue
    Total Revenue88.9101134158139
    Cost of Revenue
    Gross Profit11.138.771.76.9773.3
    Selling / General / Administrative Expenses
    Depreciation and Amortization
    Unusual Expense / Income
    Other Operating Expenses
    Total Operating Expenses259176169315128
    Operating Profit-170-75.3-34.9-15710.9
    Gain / Loss on Sale of Assets
    Total Net Non Operating Interest Income / Expense
    Other Net Non Operating Costs
    Net Income Before Taxes-208-115-41.6-157-40.5
    Provision for Income Taxes
    Net Income After Taxes-208-115-41.6-157-40.5
    Net Income Before Extraordinary Items
    Net Income-208-115-41.6-157-40.5
    Adjustments to Net Income
    Income Available to Common Shareholders Excluding Extraordinary Items
    Income Available to Common Shareholders Including Extraordinary Items
    Diluted Net Income-208-115-41.6-157-91.6
    Diluted Weighted Average Shares
    Basic EPS Including Extraordinary Items
    Diluted EPS Including Extraordinary Items
    Diluted EPS Excluding Extraordinary Items
    Normalised Income Before Taxes
    Normalised Income After Taxes
    Normalised Income Available to Common Shareholders
    Diluted Normalised EPS-12.5-12.2-4.49-13.4-9.52
    Dividends per Share